Retraction notices

In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells

Type

Retraction

Notice date

6/3/2019 0:00

Journal

Molecular Cancer Therapeutics

Publisher

American Association for Cancer Research

Notice DOI

10.1158/1535-7163.mct-19-0471

Original paper DOI

10.1158/1535-7163.mct-14-0220

Reasons

• Duplication of/in Image
• Falsification/Fabrication of Data
• Investigation by Company/Institution
• Investigation by ORI
• Misconduct - Official Investigation(s) and/or Finding(s)
• Misconduct by Author

Matching venue names

Name match only, not an authoritative journal identifier.

• Molecular Cancer Therapeutics